In 2013, much progress has occurred in gout research. Imaging continues to help elucidate aspects of pathophysiology and now suggests that healing of erosions could occur when urate levels are reduced dramatically. New genetic loci associated with hyperuricaemia have been identified and management strategies for prophylaxis of gout flares continue to evolve.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Elevated UMOD methylation level in peripheral blood is associated with gout risk
Scientific Reports Open Access 11 September 2017
-
Intestinal Microbiota Distinguish Gout Patients from Healthy Humans
Scientific Reports Open Access 08 February 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dalbeth, N. et al. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy. Arthritis Care Res. http://dx.doi.org/10.1002/acr.2205.
Becker, M. A. et al. Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Ann. Rheum. Dis. 72, 1469–1474 (2013).
Dalbeth, N. et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann. Rheum. Dis. 68, 1290–1295 (2009).
Thiele, R. G. & Schlesinger, N. Diagnosis of gout by ultrasound. Rheumatology 46, 1116–1121 (2007).
Kottgen, A. et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 45, 145–154 (2013).
Choi, H. K., De Vera, M. A. & Krishnan, E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 47, 1567–1570 (2008).
Hollis-Moffatt, J. E. et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case–control sample sets. Arthritis Rheum. 60, 3485–3492 (2009).
Mitha, E. et al. Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE2 international, phase 3, randomized, placebo-controlled trial. Rheumatology 52, 1285–1292 (2013).
Schlesinger, N. Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy. Semin. Arthritis Rheum. 42, 155–165 (2012).
Liu-Bryan, R. & Terkeltaub, R. Evil humors take their toll as innate immunity makes gouty joints TREM-ble. Arthritis Rheum. 54, 383–386 (2006).
Acknowledgements
The author wishes to thank R. Stuart (Northern Clinic, Auckland), N. Dalbeth and A. Doyle (University of Auckland), and Q. Reeves (Auckland District Health Board) for their assistance in providing images for Figure 1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
McQueen, F. Imaging, genetics and therapy: gout research continues apace. Nat Rev Rheumatol 10, 67–69 (2014). https://doi.org/10.1038/nrrheum.2013.164
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2013.164
This article is cited by
-
A crystal conundrum: a review of investigation and management of gout for the hand surgeon
European Journal of Plastic Surgery (2021)
-
Elevated UMOD methylation level in peripheral blood is associated with gout risk
Scientific Reports (2017)
-
Intestinal Microbiota Distinguish Gout Patients from Healthy Humans
Scientific Reports (2016)